查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1620661

药品品管软体市场：按功能、部署形式和最终用户划分 - 2025-2030 年全球预测

Pharmaceutical Quality Management Software Market by Function (Audit Management, Change Management, Corrective Action Preventive Action (CAPA) Management), Deployment Mode (Cloud, On-premise), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药品品管软体市值为19.4亿美元，预计2024年将达21.8亿美元，复合年增长率为12.71%，预计到2030年将达到44.8亿美元。

药品品管软体 (QMS) 在确保遵守严格的监管标准并维持药品製造和分销所需的高品质标准方面发挥关键作用。该软体促进整个製药业务的品质程序自动化、文件管理、偏差追踪和风险管理。该领域对品质管理系统的需求源于对业务效率、减少错误以及遵守 FDA 指南和 GMP 标准等法规的需求。应用范围包括文件管理、培训管理、产品设计管理以及纠正措施和预防措施 (CAPA) 管理，为製药公司、生物技术公司和受託製造厂商(CMO) 等最终用户提供支援。

主要市场统计
基准年[2023] 19.4亿美元
预计年份 [2024] 21.8亿美元
预测年份 [2030] 44.8亿美元
复合年增长率（%） 12.71%

药品品质管理系统市场受到对药品品质标准的日益关注、监管监督的加强和药品创新的增加的影响。随着医疗保健产业数位转型的不断普及，品质管理系统供应商有机会将先进的分析和人工智慧功能整合到他们的产品中，以增强流程自动化和预测品管。此外，云端基础的解决方案的趋势由于其扩充性和成本效益而显示出显着的成长前景。然而，高实施成本、资料隐私问题以及传统製药公司抵制变革等挑战可能会限制市场成长。

对公司而言，创新机会在于增强软体与现有企业系统的互通性，并开发特定产业的模组来满足利基製药需求。投资于使用者友善的介面和行动可访问性对于提高采用率也至关重要。探索人工智慧驱动的品质预测和虚拟培训模组，以进一步使您的产品在竞争格局中脱颖而出。随着市场走向数位化，企业将受益于与科技公司建立策略伙伴关係，并增强其核心能力。为了利用这些机会，公司应该专注于建立灵活且强大的解决方案，以适应不断变化的法规和市场需求，同时解决部署中的成本和复杂性限制。

市场动态：揭示快速发展的药品品管软体市场的关键市场洞察

药品品管软体市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球药品製造业持续成长
    • 日益严格的法规以维护药品品质和安全
    • 数位科技在製药领域的使用增加
  • 市场限制因素
    • 安装和维护药品品管软体的成本高昂
  • 市场机会
    • 越来越多地引入新的药品品管软体
    • 中小药的新可能
  • 市场挑战
    • 药品品管软体中的隐私和安全问题

波特五力：驾驭药品品管软体市场的策略工具

波特的五力架构是了解药品品管软体市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药品品管软体市场的外部影响

外部宏观环境因素在塑造药品品管软体市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解药品品管软体市场的竞争格局

药品品管软体市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵药品品管软体市场供应商的绩效评估

FPNV 定位矩阵是评估药品品管软体市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製药品品管软体市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对药品品管软体市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球药品製造业持续成长
      • 保障药品品质安全的严格监管范围扩大
      • 数位科技在製药业的使用增加
    • 抑制因素
      • 安装和维护药品品管软体的成本高昂
    • 机会
      • 新型药品品管软体的引进不断增加
      • 中小药的新可能
    • 任务
      • 药品品管软体中的隐私和安全问题
  • 市场区隔分析
    • 特点：药品品管软体在监管和合规管理的使用增加
    • 最终用户：製药公司广泛使用 PQM 软体来最大限度地降低产品召回的风险。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章药品品管软体市场：依功能

  • 审核管理
  • 变革管理
  • 纠正措施预防措施 (CAPA) 管理
  • 资料管理
  • 检验管理
  • 不合格管理
  • 监理与合规管理
  • 风险管理
  • 供应商管理
  • 培训管理

第七章药品品管软体市场：依部署模式

  • 云
  • 本地

第八章药品品管软体市场：依最终用户分类

  • 生技公司
  • 合约开发製造组织
  • 製药公司

第九章美洲药品品管软体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区药品品管软体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲药品品管软体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Aspen Biosciences 推出管道：彻底改变药物发现管理
    • Recipharm 利用 Veeva Vault Quality Suite 来标准化全球品管业务。
    • Certara 与 Xybion 建立策略联盟，以改善药物安全性和有效性的评估
  • 战略分析和建议

公司名单

  • AmpleLogic
  • Antares Vision SpA
  • Aspen Biosciences
  • AssurX, Inc.
  • Clario
  • ComplianceQuest
  • Dassault Systemes
  • ETQ, LLC by Hexagon AB
  • Ideagen
  • InstantGMP, Inc.
  • IQVIA Inc.
  • Korber Pharma GmbH
  • Marken
  • MasterControl Solutions Inc.
  • Oracle Corporation
  • Qualio, Inc.
  • Qualityze
  • Qualityze Inc.
  • Sarjen Systems Pvt. Ltd
  • Scilife NV
  • SimplerQMS
  • Sparta Systems, Inc. by Honeywell International Inc.
  • Veeva Systems Inc.
  • Xybion
  • Zipbooks Software Solutions Pvt. Ltd.
Product Code: MRR-5C6F41F5B03D

The Pharmaceutical Quality Management Software Market was valued at USD 1.94 billion in 2023, expected to reach USD 2.18 billion in 2024, and is projected to grow at a CAGR of 12.71%, to USD 4.48 billion by 2030.

Pharmaceutical Quality Management Software (QMS) plays a critical role in ensuring compliance with stringent regulatory standards and maintaining the high-quality standards necessary in drug manufacturing and distribution. This software automates quality procedures, manages documentation, tracks deviations, and facilitates risk management across pharmaceutical operations. The necessity of QMS in this sector is driven by the need for operational efficiency, reduction of errors, and compliance with regulations such as FDA guidelines and GMP standards. Its applications span across document control, training management, product design control, and CAPA (Corrective and Preventive Action) management, supporting end-users including pharmaceutical companies, biotechnology firms, and contract manufacturing organizations (CMOs).

KEY MARKET STATISTICS
Base Year [2023] USD 1.94 billion
Estimated Year [2024] USD 2.18 billion
Forecast Year [2030] USD 4.48 billion
CAGR (%) 12.71%

The market for Pharmaceutical QMS is influenced by the rising focus on drug quality standards, increasing regulatory scrutiny, and a growing number of pharmaceutical innovations. The surge in digital transformation initiatives across the healthcare sector has opened opportunities for QMS providers to integrate advanced analytics and AI capabilities into their offerings, enhancing process automation and predictive quality management. Additionally, the trend towards cloud-based solutions presents significant growth prospects due to their scalability and cost-effectiveness. However, challenges such as high implementation costs, data privacy concerns, and resistance to change in traditional pharmaceutical setups may restrict market growth.

For businesses, innovation opportunities lie in enhancing software interoperability with existing enterprise systems and developing industry-specific modules catering to niche pharmaceutical requirements. Investing in user-friendly interfaces and mobile accessibility is also crucial to increase adoption rates. Research into AI-driven quality prediction and virtual training modules can further differentiate offerings in the competitive landscape. As the market leans towards digitalization, companies would benefit by forming strategic partnerships with technology firms to strengthen their core capabilities. To capitalize on these opportunities, organizations should focus on creating flexible and robust solutions that can adapt to evolving regulations and market demands while addressing the limitation of cost and complexity in deployment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Quality Management Software Market

The Pharmaceutical Quality Management Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Continuous increase in manufacturing of drugs globally
    • Growing availability of stringent regulations to maintain quality and safety of drugs
    • Increasing use of digital technologies in the pharmaceutical sector
  • Market Restraints
    • High cost of installation and maintenance of pharmaceutical quality management software
  • Market Opportunities
    • Growing introduction of novel pharmaceutical quality management software
    • Emerging potential in small and mid-size pharmaceutical companies
  • Market Challenges
    • Privacy and security issues with pharmaceutical quality management software

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Quality Management Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Quality Management Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Quality Management Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Quality Management Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Quality Management Software Market

A detailed market share analysis in the Pharmaceutical Quality Management Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Quality Management Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Quality Management Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Quality Management Software Market

A strategic analysis of the Pharmaceutical Quality Management Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Quality Management Software Market, highlighting leading vendors and their innovative profiles. These include AmpleLogic, Antares Vision S.p.A, Aspen Biosciences, AssurX, Inc., Clario, ComplianceQuest, Dassault Systemes, ETQ, LLC by Hexagon AB, Ideagen, InstantGMP, Inc., IQVIA Inc., Korber Pharma GmbH, Marken, MasterControl Solutions Inc., Oracle Corporation, Qualio, Inc., Qualityze, Qualityze Inc., Sarjen Systems Pvt. Ltd, Scilife N.V., SimplerQMS, Sparta Systems, Inc. by Honeywell International Inc., Veeva Systems Inc., Xybion, and Zipbooks Software Solutions Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Quality Management Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Function, market is studied across Audit Management, Change Management, Corrective Action Preventive Action (CAPA) Management, Data Management, Inspection Management, Non-Conformances Management, Regulatory & Compliance Management, Risk Management, Supplier Management, and Training Management.
  • Based on Deployment Mode, market is studied across Cloud and On-premise.
  • Based on End-user, market is studied across Biotechnology Companies, Contract Development and Manufacturing Organizations, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Continuous increase in manufacturing of drugs globally
      • 5.1.1.2. Growing availability of stringent regulations to maintain quality and safety of drugs
      • 5.1.1.3. Increasing use of digital technologies in the pharmaceutical sector
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of installation and maintenance of pharmaceutical quality management software
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing introduction of novel pharmaceutical quality management software
      • 5.1.3.2. Emerging potential in small and mid-size pharmaceutical companies
    • 5.1.4. Challenges
      • 5.1.4.1. Privacy and security issues with pharmaceutical quality management software
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Function: Increasing use of pharmaceutical quality management software for regulatory & compliance management
    • 5.2.2. End-user: Extensive use PQM software in pharmaceutical companies to minimize the risk of product recalls
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Quality Management Software Market, by Function

  • 6.1. Introduction
  • 6.2. Audit Management
  • 6.3. Change Management
  • 6.4. Corrective Action Preventive Action (CAPA) Management
  • 6.5. Data Management
  • 6.6. Inspection Management
  • 6.7. Non-Conformances Management
  • 6.8. Regulatory & Compliance Management
  • 6.9. Risk Management
  • 6.10. Supplier Management
  • 6.11. Training Management

7. Pharmaceutical Quality Management Software Market, by Deployment Mode

  • 7.1. Introduction
  • 7.2. Cloud
  • 7.3. On-premise

8. Pharmaceutical Quality Management Software Market, by End-user

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Contract Development and Manufacturing Organizations
  • 8.4. Pharmaceutical Companies

9. Americas Pharmaceutical Quality Management Software Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pharmaceutical Quality Management Software Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Quality Management Software Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Aspen Biosciences Launches Pipeline: Revolutionizing Drug Discovery Management
    • 12.3.2. Recipharm Leverages Veeva Vault Quality Suite to Standardize Global Quality Management Operations"
    • 12.3.3. Strategic Collaboration between Certara and Xybion to Improve Drug Safety and Efficacy Evaluation
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AmpleLogic
  • 2. Antares Vision S.p.A
  • 3. Aspen Biosciences
  • 4. AssurX, Inc.
  • 5. Clario
  • 6. ComplianceQuest
  • 7. Dassault Systemes
  • 8. ETQ, LLC by Hexagon AB
  • 9. Ideagen
  • 10. InstantGMP, Inc.
  • 11. IQVIA Inc.
  • 12. Korber Pharma GmbH
  • 13. Marken
  • 14. MasterControl Solutions Inc.
  • 15. Oracle Corporation
  • 16. Qualio, Inc.
  • 17. Qualityze
  • 18. Qualityze Inc.
  • 19. Sarjen Systems Pvt. Ltd
  • 20. Scilife N.V.
  • 21. SimplerQMS
  • 22. Sparta Systems, Inc. by Honeywell International Inc.
  • 23. Veeva Systems Inc.
  • 24. Xybion
  • 25. Zipbooks Software Solutions Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY AUDIT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY CHANGE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY CORRECTIVE ACTION PREVENTIVE ACTION (CAPA) MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY INSPECTION MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY NON-CONFORMANCES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY REGULATORY & COMPLIANCE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY SUPPLIER MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY TRAINING MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023